2026 NPPES data Internal Medicine Physician NPI 1851302137 M.D.
Verify on CMS →

GOWDARA DIVAKARA MURTHY, M.D.

Internal Medicine Physician in SCHENECTADY, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 292 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$138.89
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GOWDARA DIVAKARA MURTHY, M.D. filed 3,264 Medicare Part D claims in 2023 as a Internal Medicine Physician in SCHENECTADY, New York, prescribing 77% generic.

3K
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GOWDARA DIVAKARA MURTHY, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,264 Top 11% higher than 89% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

GOWDARA DIVAKARA MURTHY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GOWDARA DIVAKARA MURTHY, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/11/2006

NPI 1851302137

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

3,264 20% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in New York

How Internal Medicine Physician compares to other specialties among New York providers

New York providers

Internal Medicine Physician share within New York

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GOWDARA DIVAKARA MURTHY, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 2546 BALLTOWN RD, SCHENECTADY, NY, 12309, with a listed phone of (518) 374-1444. NPI 1851302137 was issued on 08/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DIVAKARA MURTHY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,264 prescription claims written by this provider, covering 292 Medicare beneficiaries and totaling roughly $273K in drug spend, split 23% brand-name and 77% generic by claim count, with an opioid prescribing rate of 1.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2546 BALLTOWN RD
SCHENECTADY, NY 12309

Provider Details

NPI 1851302137
Specialty Internal Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 08/11/2006

Hospital and facility affiliations

Facilities where GOWDARA DIVAKARA MURTHY, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NEW YORK GENERAL MEDICAL SERVICES PC
ALTAMONT, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GOWDARA DIVAKARA MURTHY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$139

Largest payer

Neurocrine Biosciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to GOWDARA DIVAKARA MURTHY, M.D.. To verify GOWDARA DIVAKARA MURTHY, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

GOWDARA DIVAKARA MURTHY, M.D. — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 3,264 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,264
Total Claims
$273K
Total Drug Cost
292
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,282
Total Day Supply
76,881
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$195K
Generic Drug Cost
$76K
Opioid Claims
38 (1.2% rate)
Antibiotic Claims
27

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
3.27
Gender Split
59% female / 41% male
Age Distribution
<65: 41, 65-74: 87, 75-84: 96, 85+: 68

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GOWDARA DIVAKARA MURTHY, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
152
Eliquis
Apixaban
140
Levothyroxine Sodium
126
Amlodipine Besylate
125
Sertraline Hcl
114
Gabapentin
96
Metoprolol Succinate
84
Furosemide
80
Metoprolol Tartrate
78
Risperidone
56

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How GOWDARA DIVAKARA MURTHY, M.D. fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

GOWDARA DIVAKARA MURTHY, M.D.'s 3,264 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as DIVAKARA MURTHY.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GOWDARA DIVAKARA MURTHY, M.D.'s specialty?
GOWDARA DIVAKARA MURTHY, M.D. specializes in Internal Medicine Physician and practices in SCHENECTADY, New York. Credentials: M.D..
How much does GOWDARA DIVAKARA MURTHY, M.D. prescribe under Medicare Part D?
In 2023, GOWDARA DIVAKARA MURTHY, M.D. wrote 3,264 Medicare Part D claims totaling $273K in drug costs for 292 beneficiaries.
Where is GOWDARA DIVAKARA MURTHY, M.D. located?
GOWDARA DIVAKARA MURTHY, M.D. is located at 2546 BALLTOWN RD, SCHENECTADY, NY, 12309. Phone: (518) 374-1444.
What is GOWDARA DIVAKARA MURTHY, M.D.'s NPI number?
GOWDARA DIVAKARA MURTHY, M.D.'s National Provider Identifier (NPI) is 1851302137, issued on 08/11/2006.
Does GOWDARA DIVAKARA MURTHY, M.D. prescribe more brand-name or generic drugs?
GOWDARA DIVAKARA MURTHY, M.D.'s prescribing is 23% brand-name and 77% generic drugs by claim count, with $195K in brand drug costs.
Does GOWDARA DIVAKARA MURTHY, M.D. prescribe opioids?
Yes, GOWDARA DIVAKARA MURTHY, M.D. had 38 opioid claims in 2023 with an opioid prescribing rate of 1.2%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does GOWDARA DIVAKARA MURTHY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, GOWDARA DIVAKARA MURTHY, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Eliquis, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GOWDARA DIVAKARA MURTHY, M.D. accept Medicare?
GOWDARA DIVAKARA MURTHY, M.D. appears in CMS Medicare data with 3,264 Part D claims and 292 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GOWDARA DIVAKARA MURTHY, M.D.'s credentials?
GOWDARA DIVAKARA MURTHY, M.D.'s NPI is 1851302137 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology